Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
SAN DIEGO, California — If tissue plasminogen activator (tPA) can be shown to be effective in mild stroke in large-scale trials, it will provide good economic value to the healthcare system, a new ...
A study may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA, the 'clot busting' drug that has greatly reduced stroke-related disability ...
A new analysis suggests that about a quarter of potentially eligible patients are not receiving thrombolysis for ischemic stroke, and some of the reasons for this might be modifiable, researchers say.
Mann draws attention to 2 important points: (1) stroke outcome depends heavily on initial stroke severity as measured by the National Institutes of Health Stroke Scale (NIHSS), and (2) baseline ...
ORLANDO, Fla. (Ivanhoe Newswire) – For over 20 years, the standard of care for stroke patients has been a drug called TPA. But now, some doctors are questioning whether TPA is the best bet for ...
(HealthDay News) — Endovascular therapy with mechanical thrombectomy in ischemic stroke is superior to standard treatment with tissue plasminogen activator (tPA) for preserving brain function, ...
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. In their paper receiving ...
Among patients presenting directly to a thrombectomy-equipped center with a large-vessel ischemic stroke, going directly to the endovascular suite and forgoing initial IV thrombolytic therapy provides ...
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
Mann draws attention to 2 important points: (1) stroke outcome depends heavily on initial stroke severity as measured by the National Institutes of Health Stroke Scale (NIHSS), and (2) baseline ...
Even when its clot-dissolving powers are removed, the stroke drug tPA can still protect brain cells from the loss of oxygen and glucose induced by a stroke, researchers have discovered. The finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results